FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
7200741000172115 referentieset met attribuutwaarden voor reden voor deactivatie van concept nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


135403 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Adverse reaction to flurbiprofen Duplicate component (foundation metadata concept)
Adverse reaction to folic acid Duplicate component (foundation metadata concept)
Adverse reaction to framycetin sulfate Duplicate component (foundation metadata concept)
Adverse reaction to furosemide Duplicate component (foundation metadata concept)
Adverse reaction to gallamine triethiodide Duplicate component (foundation metadata concept)
Adverse reaction to gamma globulin Duplicate component (foundation metadata concept)
Adverse reaction to ganglion blockers NOS Limited component (foundation metadata concept)
Adverse reaction to gaseous anesthetic Duplicate component (foundation metadata concept)
Adverse reaction to gaseous anesthetic NOS Limited component (foundation metadata concept)
Adverse reaction to general anesthetic Duplicate component (foundation metadata concept)
Adverse reaction to gentamicin Duplicate component (foundation metadata concept)
Adverse reaction to glibenclamide Duplicate component (foundation metadata concept)
Adverse reaction to gliclazide Duplicate component (foundation metadata concept)
Adverse reaction to glipizide Duplicate component (foundation metadata concept)
Adverse reaction to gliquidone Duplicate component (foundation metadata concept)
Adverse reaction to glucagon Duplicate component (foundation metadata concept)
Adverse reaction to glycerol Duplicate component (foundation metadata concept)
Adverse reaction to glyceryl trinitrate Duplicate component (foundation metadata concept)
Adverse reaction to glymidine Duplicate component (foundation metadata concept)
Adverse reaction to griseofulvin Duplicate component (foundation metadata concept)
Adverse reaction to guanethidine Duplicate component (foundation metadata concept)
Adverse reaction to hallucinogen NOS Limited component (foundation metadata concept)
Adverse reaction to haloperidol Duplicate component (foundation metadata concept)
Adverse reaction to halothane Duplicate component (foundation metadata concept)
Adverse reaction to heavy metal anti-infectives Ambiguous
Adverse reaction to heavy metal anti-infectives NOS Limited component (foundation metadata concept)
Adverse reaction to heparin Duplicate component (foundation metadata concept)
Adverse reaction to homatropine Duplicate component (foundation metadata concept)
Adverse reaction to hormones and synthetic substances NOS Ambiguous
Adverse reaction to hormones and synthetic substitutes Ambiguous
Adverse reaction to hydantoin derivatives NOS Ambiguous
Adverse reaction to hydralazine Duplicate component (foundation metadata concept)
Adverse reaction to hydrochlorothiazide Duplicate component (foundation metadata concept)
Adverse reaction to hydrocortisone Ambiguous
Adverse reaction to hydroflumethiazide Duplicate component (foundation metadata concept)
Adverse reaction to hydroxocobalamin Duplicate component (foundation metadata concept)
Adverse reaction to hydroxyprogesterone hexanoate Duplicate component (foundation metadata concept)
Adverse reaction to hydroxyurea Duplicate component (foundation metadata concept)
Adverse reaction to hydroxyzine Duplicate component (foundation metadata concept)
Adverse reaction to hyoscine Duplicate component (foundation metadata concept)
Adverse reaction to idoxuridine Duplicate component (foundation metadata concept)
Adverse reaction to imipramine Duplicate component (foundation metadata concept)
Adverse reaction to indomethacin Duplicate component (foundation metadata concept)
Adverse reaction to inosine pranobex Duplicate component (foundation metadata concept)
Adverse reaction to insulins Duplicate component (foundation metadata concept)
Adverse reaction to insulins and antidiabetic agents Ambiguous
Adverse reaction to insulins and antidiabetic agents Ambiguous
Adverse reaction to insulins and antidiabetic agents NOS Ambiguous
Adverse reaction to intravenous anesthetic Duplicate component (foundation metadata concept)
Adverse reaction to intravenous anesthetic NOS Limited component (foundation metadata concept)
Adverse reaction to intravenous electrolytes and/or trace elements Ambiguous
Adverse reaction to iodine or iodide Ambiguous
Adverse reaction to ipecacuanha Duplicate component (foundation metadata concept)
Adverse reaction to ipratropium bromide Duplicate component (foundation metadata concept)
Adverse reaction to iron and iron compounds Ambiguous
Adverse reaction to iron and iron compounds NOS Limited component (foundation metadata concept)
Adverse reaction to iron dextran injection Ambiguous
Adverse reaction to iron sorbitol injection Duplicate component (foundation metadata concept)
Adverse reaction to irritant cathartics NOS Limited component (foundation metadata concept)
Adverse reaction to isocarboxazid Duplicate component (foundation metadata concept)
Adverse reaction to isoflurane Duplicate component (foundation metadata concept)
Adverse reaction to isoniazid Duplicate component (foundation metadata concept)
Adverse reaction to isoprenaline sulfate Duplicate component (foundation metadata concept)
Adverse reaction to isosorbide dinitrate Duplicate component (foundation metadata concept)
Adverse reaction to isosorbide mononitrate Duplicate component (foundation metadata concept)
Adverse reaction to isoxsuprine Duplicate component (foundation metadata concept)
Adverse reaction to kanamycin Duplicate component (foundation metadata concept)
Adverse reaction to kaolin Duplicate component (foundation metadata concept)
Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations Limited component (foundation metadata concept)
Adverse reaction to ketamine Duplicate component (foundation metadata concept)
Adverse reaction to ketazolam Duplicate component (foundation metadata concept)
Adverse reaction to ketoconazole Duplicate component (foundation metadata concept)
Adverse reaction to labetalol Duplicate component (foundation metadata concept)
Adverse reaction to lactulose Duplicate component (foundation metadata concept)
Adverse reaction to lanatoside C Duplicate component (foundation metadata concept)
Adverse reaction to lead compound Duplicate component (foundation metadata concept)
Adverse reaction to levodopa, L-dopa Duplicate component (foundation metadata concept)
Adverse reaction to levorphanol tartrate Duplicate component (foundation metadata concept)
Adverse reaction to lignocaine hydrochloride Duplicate component (foundation metadata concept)
Adverse reaction to lincomycin Duplicate component (foundation metadata concept)
Adverse reaction to liothyronine sodium Duplicate component (foundation metadata concept)
Adverse reaction to liver preparations and other antianemic agents NOS Classification derived component
Adverse reaction to local anesthetics NOS Limited component (foundation metadata concept)
Adverse reaction to local anti-infective or anti-inflammatory drug NOS Limited component (foundation metadata concept)
Adverse reaction to local anti-infectives and anti-inflammatory drugs Ambiguous
Adverse reaction to lofepramine Duplicate component (foundation metadata concept)
Adverse reaction to lomustine Duplicate component (foundation metadata concept)
Adverse reaction to loperamide Duplicate component (foundation metadata concept)
Adverse reaction to lorazepam Duplicate component (foundation metadata concept)
Adverse reaction to lymecycline Duplicate component (foundation metadata concept)
Adverse reaction to lypressin Duplicate component (foundation metadata concept)
Adverse reaction to macrolide NOS Limited component (foundation metadata concept)
Adverse reaction to macrolide group Duplicate component (foundation metadata concept)
Adverse reaction to macrolide group Duplicate component (foundation metadata concept)
Adverse reaction to magnesium sulfate Duplicate component (foundation metadata concept)
Adverse reaction to magnesium trisilicate Duplicate component (foundation metadata concept)
Adverse reaction to mannitol Duplicate component (foundation metadata concept)
Adverse reaction to maprotiline Duplicate component (foundation metadata concept)
Adverse reaction to measles vaccine Duplicate component (foundation metadata concept)
Adverse reaction to mebendazole Duplicate component (foundation metadata concept)
Adverse reaction to mebeverine Duplicate component (foundation metadata concept)

Start Previous Page 78 of 1355 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start